Processa Pharmaceuticals, Inc. Other Revenue, Net (Deprecated 2018-01-31)
Processa Pharmaceuticals, Inc. (PCSA) reported Other Revenue, Net (Deprecated 2018-01-31) of $38.83 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-09-25.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2017-09-25
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-12-31 was -$6.75K, a 635.40% decline year-over-year.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $40.57K.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $5.00K.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $38.83K, a 534.41% increase from fiscal 2014.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $6.12K, a 82.01% decline from fiscal 2013.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2013 was $34.02K, a 1600.85% increase from fiscal 2012.
- Processa Pharmaceuticals, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2012 was $2.00K.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 12 month | Other Revenue, Net (Deprecated 2018-01-31) 27 month | Other Revenue, Net (Deprecated 2018-01-31) 30 month | Other Revenue, Net (Deprecated 2018-01-31) 33 month | Other Revenue, Net (Deprecated 2018-01-31) 36 month |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | -$6.75K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $33.83K derived: sum of 2 quarters · filed 2017-09-25 | $33.83K derived: sum of 3 quarters · filed 2017-09-25 | $38.83K 10-K · filed 2017-09-25 | ||||
| 2015-09-30 | $40.57K 10-Q · filed 2017-09-08 | $40.57K derived: sum of 2 quarters · filed 2017-09-08 | $45.57K 10-Q · filed 2017-09-08 | $46.83K derived: sum of 4 quarters · filed 2017-09-08 | ||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $5.00K 10-Q · filed 2017-08-30 | $6.26K derived: sum of 3 quarters · filed 2017-08-30 | $6.26K derived: sum of 4 quarters · filed 2017-08-30 | ||||
| 2015-03-31 | $5.00K 10-Q · filed 2017-08-07 | $6.26K derived: sum of 2 quarters · filed 2017-08-07 | $6.26K derived: sum of 3 quarters · filed 2017-08-07 | $11.12K derived: sum of 4 quarters · filed 2017-08-07 | ||||
| 2014-12-31 | $1.26K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $1.26K derived: sum of 2 quarters · filed 2017-06-19 | $6.12K derived: sum of 3 quarters · filed 2017-06-19 | $6.12K 10-K · filed 2017-06-19 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $4.86K derived: sum of 2 quarters · filed 2015-12-01 | $4.86K 10-Q · filed 2015-12-01 | $30.41K derived: sum of 4 quarters · filed 2015-12-01 | ||||
| 2014-06-30 | $4.86K 10-Q · filed 2015-08-19 | $4.86K 10-Q · filed 2015-08-19 | $30.41K derived: sum of 3 quarters · filed 2015-08-19 | $37.60K derived: sum of 4 quarters · filed 2015-08-19 | ||||
| 2014-03-31 | $0.00 derived: 10-Q 36 month − 10-K 33 month · filed 2014-05-14 | $25.55K derived: sum of 2 quarters · filed 2015-04-14 | $32.74K derived: sum of 3 quarters · filed 2015-04-14 | $34.02K derived: sum of 4 quarters · filed 2015-04-14 | $51.55K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $25.55K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $32.74K derived: sum of 2 quarters · filed 2015-04-14 | $34.02K derived: sum of 3 quarters · filed 2015-04-14 | $34.02K 10-K · filed 2015-04-14 | $51.55K 10-K · filed 2014-03-27 | |||
| 2013-09-30 | $7.18K 10-Q · filed 2014-11-13 | $8.46K derived: sum of 2 quarters · filed 2014-11-13 | $8.46K 10-Q · filed 2014-11-13 | $26.00K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $1.28K 10-Q · filed 2014-08-19 | $1.28K 10-Q · filed 2014-08-19 | $18.81K 10-Q/A · filed 2013-09-06 | |||||
| 2012-12-31 | $1.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $2.00K derived: sum of 2 quarters · filed 2014-03-27 | $2.00K 10-K · filed 2014-03-27 | |||||
| 2012-09-30 | $500.00 10-Q · filed 2013-11-08 | $500.00 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |